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ABSTRACT
Objective: The aim of this study was to evaluate our
experience with laparoscopic splenectomy in pediatric
patients with hematologic diseases.
Methods: A retrospective chart review was performed
to analyze the following:  indication for splenectomy,
pre- and peri-operative management, surgical technique,
complications, duration of hospitalization, and outcome.
Results: Eleven patients underwent laparoscopic
splenectomy for the following indications:  recurrent
thrombocytopenia (<10,000) in seven with chronic
immune thrombocytopenic purpura; anemia in two with
hereditary spherocytosis; and hypersplenism in one and
recurrent splenic sequestration in another with homozy-
gous hemoglobin S.  The six girls and five boys had a
median age of 7 years.  The median operative time was
180 minutes, and the median hospitalization was 72
hours.  Among the patients with immune thrombocy-
topenic purpura (median platelet count, 153,000), those
patients (n=3) with platelet counts of <100,000 did not
suffer any bleeding complications.  The patient with
hypersplenism and homozygous hemoglobin S required
a small incision in the left lower quadrant to facilitate
removal of a 558-gram spleen.  This patient also under-
went cholecystectomy for cholelithiasis.  The operative
time was 295 minutes, and he was hospitalized for 5 days
because of atelectasis.
Conclusions: Laparoscopic splenectomy is a safe and
effective procedure in children with hematological disor-
ders.
Key Words: Hematologic diseases, Splenectomy,
Laparoscopic surgery, Child, Adolescence.
INTRODUCTION
With the advent of minimally invasive techniques,
laparoscopic splenectomy has emerged as the treatment
of choice for patients with hematologic diseases
(immune thrombocytopenic purpura [ITP], hereditary
spherocytosis [HS], autoimmune hemolytic anemia, and
homozygous hemoglobin S [SS] disease).  Although the
operative time is longer using laparoscopic techniques,
the need for postoperative analgesics is reduced, and
hospitalizations are shorter.1 Moreover, cosmetic results
are excellent, and patients can resume normal activities
sooner.  One obstacle to laparoscopic splenectomy is the
detection of accessory spleens and splenosis.2,3 But,
with meticulous technique, this obstacle can be mini-
mized.  In the present report, we describe our single-
institution experience with laparoscopic splenectomy in
pediatric patients with hematologic diseases.
PATIENTS AND METHODS
Between August 1996 and February 1999, 11 patients
with hematological disorders underwent laparoscopic
splenectomy performed by one pediatric surgeon (GS).
There were six females and five males.  Their median
age was 7 years (range, 3.5 to 19 years) at the time of
surgery.  The indications for splenectomy were as fol-
lows:  recurrent thrombocytopenia (<10,000) in ITP
(n=7), anemia and hemolysis in HS (n=2), and hyper-
splenism (n=1) and recurrent splenic sequestration (n=1)
in SS.  Preoperative ultrasonography was done in all
patients with hemolytic disorders to exclude cholelithia-
sis.  Gallstones were encountered in one patient, who
subsequently underwent cholecystectomy performed
concurrently with splenectomy.
Operative Procedure
The operation was performed with the patient under
general anesthesia in the right lateral decubitus position.
This position allowed for the spleen to be suspended in
the left upper quadrant by the splenic ligaments.  At least
three ports, as always required, were used for this pro-
cedure:  a 5-mm port in the epigastrium, a 12-mm port
in the left lower quadrant, and a 5-mm port in between.
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The 12-mm port was utilized to introduce the automatic
endoscopic stapler (Endo GIA 30; U.S. Surgical
Corporation, Norwalk, CT) and subsequently to place the
plastic specimen-retrieval bag (Endo Catch; U.S. Surgical
Corporation) to remove the spleen.  A fourth port was
needed in some cases to manipulate the spleen (it could
be a mini 3-mm port or a 5-mm port) and was placed in
the left flank posteriorly to dissect behind the spleen.  In
most cases, bipolar cutting forceps (Everest Medical
Corporation, Minneapolis, MN) were used, while in a few
cases the ultrasonic scalpel (U.S. Surgical Corporation)
was used.  The use of surgical clips was kept to a mini-
mum whenever possible because they could interfere
with the automatic stapler and cause bleeding.  
The gastrosplenic ligament was divided at first.  Initially,
only the division of ligaments that was needed to expose
the splenic hilum was performed.  The remaining liga-
ments were preserved until the end of the operation in
order to keep the spleen suspended in the left upper
quadrant.  The first branch of the blood supply from the
gastroepiploic artery to the lower pole of the spleen was
then divided.  The splenic hilum was divided close to the
spleen with the Endo GIA 30-2.0 vascular staples.
Generally, two or three applications were necessary to
completely divide the blood supply, including the short
gastric vessels; in some cases, the remaining short gastric
vessels could be divided with the bipolar cautery or ultra-
sonic scalpel.  During application of the stapler, care was
exercised to avoid the tail of the pancreas and the greater
gastric curvature.  After the blood supply had been divid-
ed, all the ligaments were transected with the bipolar for-
ceps or ultrasonic scalpel.
The spleen was placed inside the Endo Catch, and the
opening of the bag was pulled out through the 12-mm
port.  The spleen was fragmented inside the bag with the
finger or a ring blunt clamp and suction.  This part of the
procedure required careful attention to prevent rupture of
the bag, which was watched from the inside.  The spleen
could be removed in small pieces.  After the spleen was
removed, care was taken to avoid contamination of the
wounds or abdomen with splenic tissue in order to pre-
vent splenosis.
At the beginning and at the end of the operation, a care-
ful and methodical search was done to exclude accesso-
ry spleens.  Long-acting local anesthesia (bupivacaine)
was applied in all ports, and, finally, the ports were
closed in the usual manner.
RESULTS
Laparoscopic splenectomy was achieved in all patients,
with no conversions to an open procedure needed.
There were no operative complications.  Blood loss was
generally <20 mL in all patients.  The median operative
time was 180 minutes (range, 110 to 295 minutes).  In
addition to undergoing splenectomy, one of the patients
with SS also had a cholecystectomy (total operative time,
295 minutes).  The median hospitalization was 72 hours
(range, 48 to 120 hours).  The patient hospitalized for
120 hours had hypersplenism and SS and developed
right upper lobe atelectasis postoperatively.  This was the
only postoperative complication in our series.
The patients with ITP had a median platelet count of
153,000 (range, 52,000 to 296,000) prior to surgery.  In
order to achieve the best possible platelet count, intra-
venous immunoglobulin (IVIG) with methylprednisolone
and IVIG alone in two cases each and IVIG followed by
prednisone, anti-D with prednisone, and anti-D alone in
one case each were administered one to two weeks prior
to splenectomy.  Noteworthy was the fact that the
patients with platelet counts of 52,000, 58,000, and
91,000 did not suffer any intra- or postoperative bleeding
complications.
In the patient with hypersplenism and SS, a small inci-
sion in the left lower quadrant was needed to facilitate
the removal of a 558-gram spleen measuring 18 x 13 x 6
cm that extended 14 cm below the left costal margin.
The patient with recurrent sequestrative crises and SS
had a 120-gram spleen measuring 13 x 10 x 5 cm which
extended 6 cm below the left costal margin and which
was easily removed through the trocar.
Two patients with chronic ITP have not yet achieved
normal platelet counts postsplenectomy (24 months and
4 months).  One patient has required treatment with IVIG
at three different times because of platelet counts
<15,000.  This patient had an accessory spleen removed
at the time of laparoscopy.  A heat-damaged red cell
study demonstrated no evidence of accessory splenic tis-
sue.  The other patient has had platelet counts ranging
from 30,000 to 40,000, and, with the exception of a few
petechiae, is asymptomatic.  In both patients with HS, the
anemia and reticulocytosis resolved.DISCUSSION
Laparoscopic splenectomy has become the treatment of
choice for pediatric patients with hematologic diseases.
Compared with open splenectomy, its advantages
include shorter hospitalization, reduced need for postop-
erative narcotic analgesia, and excellent cosmetic results.
In seven reports of pediatric laparoscopic splenectomy,
the median duration of hospitalization ranged from 1.4
days to 3.6 days.4-10 In four studies,6,8-10 the hospitaliza-
tion was shorter when compared to open splenectomy,
and in one study there was no difference.5 In our series,
the median hospitalization time of 3 days was no differ-
ent from that of other published series.  Perhaps more
aggressive postoperative care and physician evaluation
the day after discharge may shorten the hospitalization
even further.
Patients with chronic ITP may require splenectomy
because of thrombocytopenia refractory to medical man-
agement.  In some of these patients, it may not be pos-
sible to achieve a normal platelet count preoperatively.
In three of our seven patients with chronic ITP, the
platelet counts were <100,000 (52,000, 58,000, and
91,000).  None of these three patients suffered any bleed-
ing complications during or after splenectomy.  Tulman
et al4 described a patient with refractory chronic ITP who
underwent an uncomplicated laparoscopic splenectomy
with a platelet count of 20,000.  In a study by Gigot et
al,7 two pediatric patients had preoperative platelet
counts of <60,000.  Neither of these two patients experi-
enced any hemorrhagic complications.  Therefore, a nor-
mal platelet count may not be necessary when perform-
ing a laparoscopic splenectomy.  Although a safe platelet
count has not yet been determined, a value near 50,000
may be adequate.
In our series, one patient with homozygous SS disease
developed acute chest syndrome after a combined
laparoscopic cholecystectomy and splenectomy.  This
patient was transfused with two units of packed red
blood cells preoperatively (hemoglobin 8.8 g/dL
increased to 13.2 g/dL).  The patient was hospitalized for
5 days after the procedure.  The patient had a history of
acute chest syndrome 18 months prior to surgery.
Perhaps the rise in the hemoglobin may have contributed
to this event.
In a study by Farah et al,9 6 of 13 patients with sickle cell
disease developed acute chest syndrome after splenecto-
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my (four after laparoscopic and two after open proce-
dures).  These patients were hospitalized for seven to
nine days postoperatively.  Only six of the 13 sickle cell
patients (two in the laparoscopic group and four in the
open group) received preoperative blood transfusions;
however, it is not clear which patients developed acute
chest syndrome.  Although patients with sickle cell dis-
ease experience more painful crises and episodes of
acute chest syndrome postsplenectomy, the operation
does not increase the risk of death or bacteremic illness
and should not be deferred for these reasons.11 In accor-
dance with a recent study,12 patients with sickle cell dis-
ease should receive a blood transfusion to increase the
hemoglobin level to 10 g/dL.  Adherence to these guide-
lines may prevent postoperative morbidity in these
patients.
Residual splenic function is a concern after laparoscopic
splenectomy.  This may result from splenosis or unde-
tected accessory spleens.2,3 Improvements in technique
and surgical instruments may reduce the incidence of
residual splenic function.  In one of our ITP cases, an
accessory spleen was discovered laparoscopically.  The
patient’s ITP recurred three months postoperatively.  A
heat-damaged red cell study demonstrated no evidence
of accessory splenic tissue.  Currently, this patient has a
normal platelet count.
CONCLUSIONS
Laparoscopic splenectomy provides safe and effective
treatment in pediatric patients with hematologic diseases.
Platelet counts of <100,000 should not deter a surgeon
from operating laparoscopically.  Patients with sickle cell
disease must be monitored for the occurrence of acute
chest syndrome.  Furthermore, to ensure good outcomes,
meticulous surgical technique may decrease the inci-
dence of residual splenic tissue.
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